Navigating Therapeutic Plasma Exchange in Critically Ill Children: A Retrospective Review of Indications, Timing, Outcomes, and Complications in a Developing Nation PICU
Journal of Clinical Apheresis · 2026-06 · 41 (3)
DOI: 10.1002/jca.70133 ↗At a glance
Beobachtungsstudie in Journal of Clinical Apheresis, published online on 2026-05-17. Written by Siddannagoud Salatogi and 7 co-authors. Institution: Department of Pediatrics, All-India Institute of Medical Sciences (AIIMS), Raipur, India. Major MEDLINE topics: Plasma Exchange, Critical Illness. 16 references.
Topics: Kinderkrankenpflege
Abstract (original language)
To retrospectively review the indications, timing, outcomes, and complications of membrane‐based therapeutic plasma exchange (mTPE) in critically ill children at a single‐center pediatric intensive care unit (PICU). Retrospective observational study. A tertiary‐care PICU at All‐India Institute of Medical Sciences (AIIMS), Raipur. A total of 106 patients aged 1 month to 18 years who underwent mTPE between January 2022 and December 2024. Patients had a median age of 144 months (IQR: 13–216). Renal and hepatic diseases were the most common indications. Overall, 61.3% of patients recovered and were discharged. Complications (inclusive of minor and line‐related events) were observed in 35.8% of patients. Logistic regression analysis identified fluid‐refractory shock at admission ( p < 0.001), elevated Pediatric Risk of Mortality (PRISM‐3) scores ( p = 0.007), and concurrent continuous renal replacement therapy (CRRT) ( p = 0.016) as statistically significant predictors of mortality. In the subgroup of patients with liver disease, time to mTPE initiation was an independent, significant predictor of mortality ( p = 0.013). Membrane‐based therapeutic plasma exchange is a safe and feasible adjunct therapy in critically ill children. While mTPE is most effective for conditions classified as American Society for Apheresis (ASFA) category I, its outcomes are highly variable and are significantly influenced by the underlying condition and the timing of the intervention, particularly for acute liver failure.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pediatrics, All-India Institute of Medical Sciences (AIIMS), Raipur, India.
- Division of Pediatric Pulmonology and Critical Care, Department of Pediatrics, All-India Institute of Medical Sciences (AIIMS), Raipur, India.
- Department of Nephrology, All-India Institute of Medical Sciences (AIIMS), Raipur, India.
ORCID profiles: Sathwik Gangireddy, Vinay Rathore, Varun Angadi, Atul Jindal
Cite
APA
Salatogi, S., Gangireddy, S., Sahoo, M. R., Rathore, V., Kambagiri, P., Verma, S., Angadi, V., & Jindal, A. (2026). Navigating Therapeutic Plasma Exchange in Critically Ill Children: A Retrospective Review of Indications, Timing, Outcomes, and Complications in a Developing Nation PICU. Journal of Clinical Apheresis, 41(3). https://doi.org/10.1002/jca.70133
Vancouver
Salatogi S, Gangireddy S, Sahoo MR, Rathore V, Kambagiri P, Verma S, et al. Navigating Therapeutic Plasma Exchange in Critically Ill Children: A Retrospective Review of Indications, Timing, Outcomes, and Complications in a Developing Nation PICU. Journal of Clinical Apheresis. 2026;41(3). doi:10.1002/jca.70133
BibTeX
@article{Salatogi2026,
author = {Salatogi, Siddannagoud and Gangireddy, Sathwik and Sahoo, Manas R and Rathore, Vinay and Kambagiri, Pratyusha and Verma, Shubham and Angadi, Varun and Jindal, Atul},
title = {Navigating Therapeutic Plasma Exchange in Critically Ill Children: A Retrospective Review of Indications, Timing, Outcomes, and Complications in a Developing Nation PICU},
journal = {Journal of Clinical Apheresis},
year = {2026},
volume = {41},
number = {3},
doi = {10.1002/jca.70133}
}
EUVIMED